COPYRIGHT© 2018 吉林紫鑫药业股份有限公司
Jilin Zixin Pharmaceutical Co., Ltd. Announcement on Shareholder Equity Pledge
Stock code: 002118 Securities abbreviation: Zixin Pharmaceutical Industry Bulletin No.: 2014-015
Jilin Zixin Pharmaceutical Co., Ltd.
Announcement on shareholder equity pledge
The company and all members of the board of directors guarantee that the content of the information disclosure is true, accurate and complete, and there are no false records, misleading statements or major omissions.
On March 3, 2014, the company received the controlling shareholder Dunhua Kangping Investment Co., Ltd. (hereinafter referred to as Kangping Company). Notice: On February 28, 2014, Kangping will hold 14,600,000 shares of its unrestricted shares. The stock (accounting for 2.85% of the company's total share capital) was pledged to the Changchun Hongqi Street Sub-branch of China Merchants Bank Co., Ltd., and the pledge registration formalities were handled at China Securities Depository and Clearing Co., Ltd. Shenzhen Branch. The pledge period is from February 28, 2014. The date on which the pledgee has completed the pledge registration formalities.
As of the date of this announcement, Kangping Company holds a total of 251,475,016 shares of the company, and pledges 250,610,000 shares of the company (accounting for 99.66% of the shares held by Kangping Company), accounting for 48.85% of the company's total share capital.
Jilin Zixin Pharmaceutical Co., Ltd. Board of Directors
March 4, 2014